Dov Elefant

2021 - Cellectar Biosciences

In 2021, Dov Elefant earned a total compensation of $838.2K as Former Vice President and Chief Financial Officer at Cellectar Biosciences, a 78% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$85,655
Option Awards$395,600
Salary$356,895
Total$838,150

Elefant received $395.6K in option awards, accounting for 47% of the total pay in 2021.

Elefant also received $85.7K in non-equity incentive plan and $356.9K in salary.

Rankings

In 2021, Dov Elefant's compensation ranked 9,342nd out of 12,415 executives tracked by ExecPay. In other words, Elefant earned more than 24.8% of executives.

ClassificationRankingPercentile
All
9,342
out of 12,415
25th
Division
Manufacturing
4,141
out of 5,501
25th
Major group
Chemicals And Allied Products
1,826
out of 2,374
23rd
Industry group
Drugs
1,620
out of 2,095
23rd
Industry
Pharmaceutical Preparations
1,202
out of 1,542
22nd
Source: SEC filing on April 29, 2022.

Elefant's colleagues

We found three more compensation records of executives who worked with Dov Elefant at Cellectar Biosciences in 2021.

2021

James Caruso

Cellectar Biosciences

Chief Executive Officer

2021

Jarrod Longcor

Cellectar Biosciences

Chief Operating Officer

2021

John Friend

Cellectar Biosciences

Chief Medical Officer

News

You may also like